Screener
Rapport Therapeutics, Inc. RAPP Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $2,796 | $4,190 |
| Accrued expenses and other current liabilities | 23,155 | 12,104 |
| Operating lease liability | 2,473 | 2,755 |
| Total current liabilities | 28,424 | 19,049 |
| Operating lease liability, net of current portion | 7,632 | 8,729 |
| Total liabilities | 36,056 | 27,778 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s accrued expenses?
- Rapport Therapeutics, Inc. (RAPP) reported accrued expenses of $23.16M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s accrued expenses changed year-over-year?
- Rapport Therapeutics, Inc.'s accrued expenses increased by 233.5% year-over-year, from $6.94M to $23.16M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s accrued expenses?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s accrued expenses has grown at a 46.6% compound annual growth rate (CAGR), from $5.63M to $12.1M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Rapport Therapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude